- Mass spectrometry, a powerful analytical technique for identifying and quantifying chemical compounds, is becoming increasingly essential in diverse sectors such as pharmaceuticals, biotechnology, environmental testing, and food safety due to its high sensitivity, precision, and ability to analyze complex mixtures
- The surging demand for mass spectrometry in North America is primarily driven by expanding pharmaceutical and biotech research, the growing emphasis on personalized medicine, and rising regulatory requirements for accurate and reliable analytical results
- U.S. dominated the North America mass spectrometry market with the largest revenue share of 78.9% in 2024, attributed to robust R&D spending, strong academic and industrial research infrastructure, and the presence of leading mass spectrometer manufacturers actively innovating to meet evolving scientific needs
- Canada is projected to witness the fastest growth in the region during the forecast period due to increasing investments in healthcare research, environmental monitoring initiatives, and growing collaborations between public institutions and private companies
- The hybrid mass spectrometry segment dominated the market with a share of 41.2% in 2024, driven by its superior analytical capabilities combining multiple detection techniques, which are widely adopted in proteomics, metabolomics, and complex sample analysis
